Europe follows a similar pattern, with data from the EU Clinical Trials Information System (CTIS) estimating that less than 0 ...

MarkHerz inks MoU with Technical University of Munich Hospital to develop cardiovascular and diabetes-targeted AAV gene therapies: Munich Thursday, June 5, 2025, 15:00 Hrs [IST] M ...

SHANGHAI, China and CHICAGO, IL, USA I June 5, 2025 I The 2025 ASCO Annual Meeting is taking place in Chicago, US, from May 30 to June 3. Duality Bio ...

The Chronicle spoke with Duke alumnus and professor Robert Califf about the recent “Make America Healthy Again” report and ...

By Hugo Francisco de Souza A groundbreaking phase 2a study reveals that rentosertib, an AI-developed TNIK inhibitor, could ...

There are 182 clinical trials for Alzheimer’s treatments under way in 2025—an 11% increase on the previous year—testing 138 ...

SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of ...

Specialist expertise, months of due dilligence, and high conviction investments - KP Rx's formula for healthcare growth ...

Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...

New York (AFP) | 05/06/2025 - 03:56:52 | Harvard calls Trump ban on its new foreign students 'retaliatory' ...